Executive summary
A diagnostic that establishes the factual pricing and packaging baseline, and the evidence gaps, before any redesign option is debated.
What is inside
What the diagnostic covers
The asset walks a pricing team from a signed scope note through transaction assembly, price realization analysis, the package mix baseline and win-loss evidence to a scored evidence inventory and a formal baseline acceptance. It defines every measure used later in the pathway, sets numeric quality thresholds for each input, and ends with a diagnostic questionnaire and an evidence register the team keeps using through the redesign.
- Scope: one pricing baseline across products, channels and a 12-month transaction window
- The route from list price to the price actually kept, and where value leaks on the way
- How widely realized prices vary across deals, accounts and segments
- The package and bundle baseline, including attach rates and bundle pricing practice
- What structured win-loss evidence says about price level and package fit
- A scored evidence inventory with a named owner for every gap
- The acceptance step that locks the baseline for the rest of the redesign pathway